Moderna seeks COVID-19 vaccine booster clearance in older adults, high-risk individuals

Related Articles

imageStock Markets6 minutes ago (Oct 12, 2021 09:10AM ET)

(C) Reuters. FILE PHOTO: Syringes filled with a dose of the Moderna COVID-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, U.S., September 24, 2021. REUTERS/Shannon Stapleton

(Reuters) – Moderna (NASDAQ:MRNA) Inc on Tuesday said the U.S. Food and Drug Administration should authorize booster doses of its COVID-19 vaccine in fully vaccinated older adults and other high-risk individuals.

The company said its data supports the public health benefit of a booster dose of its vaccine to restore immune response, while reducing the number of “breakthrough” infections in fully-vaccinated adults.

Moderna’s comments were released in briefing documents ahead of a Thursday meeting of the FDA’s outside expert advisers to discuss the booster dose.

Moderna seeks COVID-19 vaccine booster clearance in older adults, high-risk individuals

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Subscribe

Category

Popular stories